ARTL Artelo Biosciences, Inc.

NSC
$0.79

Artelo Biosciences, Inc. (ARTL) is expected to report earnings on November 11, 2026, before the market open.

Artelo Biosciences Reported Earnings
Thursday, August 13, 2026 · 8:00 AM ET
Earnings Date
Nov 11
Wednesday · 8:00 AM ET
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Artelo Biosciences, Inc.

Artelo Biosciences, Inc. is a San Diego-based biopharmaceutical company dedicated to the development and commercialization of proprietary therapeutics targeting lipid signaling pathways including the endocannabinoid system.

Sector

Healthcare

Industry

Biotechnology